Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting.
Faber, Edgar
Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting. [electronic resource] - Annals of hematology Jun 2012 - 923-9 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
1432-0584
10.1007/s00277-011-1394-x doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--analysis
Benzamides
Biomarkers, Pharmacological--analysis
Blood Chemical Analysis
Clinical Laboratory Techniques
Diagnostic Tests, Routine
Female
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood
Male
Middle Aged
Piperazines--analysis
Predictive Value of Tests
Prognosis
Pyrimidines--analysis
Retrospective Studies
Treatment Outcome
Young Adult
Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting. [electronic resource] - Annals of hematology Jun 2012 - 923-9 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
1432-0584
10.1007/s00277-011-1394-x doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--analysis
Benzamides
Biomarkers, Pharmacological--analysis
Blood Chemical Analysis
Clinical Laboratory Techniques
Diagnostic Tests, Routine
Female
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood
Male
Middle Aged
Piperazines--analysis
Predictive Value of Tests
Prognosis
Pyrimidines--analysis
Retrospective Studies
Treatment Outcome
Young Adult